Login / Signup

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease.

Michal PochopienJakub Wladyslaw DziedzicSamuel AballeaEmilie ClayIwona ZerdaMondher ToumiBorislav Borissov
Published in: Journal of market access & health policy (2024)
This study highlighted the potential benefits of therapies aimed at curing a disease rather than stopping its progression. Nonetheless, each of the analyzed therapies could be cost-effective compared with lifestyle intervention at a relatively high price.
Keyphrases
  • randomized controlled trial
  • metabolic syndrome
  • physical activity
  • weight loss
  • type diabetes
  • climate change
  • human health